FDA inspection
First Time US Pharmaceuticals (India) Pvt Ltd.: FDA inspection ending Mar 14, 2024
FDA inspection 1233212 · Voluntary Action Indicated (VAI) · Navi Mumbai
Key facts
| Inspection ID | 1233212 |
|---|---|
| Firm | First Time US Pharmaceuticals (India) Pvt Ltd. |
| FEI number | 3011103533 |
| Address | 1st Floor, C - 112 Pawane Midc |
| City | Navi Mumbai |
| Country | India |
| Fiscal year | 2024 |
| Inspection end date | Mar 14, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data